SciELO - Scientific Electronic Library Online

 
vol.35 número1Frecuencia y factores de riesgo para bacteriemia por enterobacterias productoras de betalactamasa de espectro extendido en pacientes de un hospital público de Lima, PerúPolimorfismos del gen arsénico 3 metiltransferasa (As3MT) y la eficiencia urinaria del metabolismo del arsénico en una población del norte de México índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Peruana de Medicina Experimental y Salud Publica

versão impressa ISSN 1726-4634

Resumo

LIFONZO-MUCHA, Sheyber J; TAMARIZ-ZAMUDIO, Paula E  e  CHAMPI-MERINO, Roky G. Sensitivity to fosfomycin in extended-spectrum beta-lactamase-producing Escherichia coli. Rev. perú. med. exp. salud publica [online]. 2018, vol.35, n.1, pp.68-71. ISSN 1726-4634.  http://dx.doi.org/10.17843/rpmesp.2018.351.3566.

Urinary infections are caused mainly by Escherichia coli (E. coli); indiscriminate use of antibiotics has caused an increase in infections due to extended-spectrum beta-lactamase (ESBL)-producing strains. Aiming to determine the sensitivity to fosfomycin, a study was conducted in ESBL-producing E. coli strains isolated from urine cultures at a hospital in Peru. Two hundred and sixty-six (266) strains of E. coli were collected, which were determined by conventional methods to be ESBLproducing. Sensitivity to fosfomycin was determined through minimum inhibitory concentration with the agar dilution method and the diffusion disc method. One hundred and ninety-two (192) (72.2%) strains of ESBL-producing E. coli strains sensitive to Fosfomycin were found. It, therefore, follows that fosfomycin exhibits antimicrobial activity against ESBL-producing E. coli strains and that it could be considered a good treatment option for resistant strains.

Palavras-chave : Escherichia coli; Betalactamases; Fosfomycin; Urinary infections.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons